Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.573 USD | +3.34% | -1.90% | -37.21% |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 4.17M | Capitalization | 125M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -188M | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | 60.4 x |
P/E ratio 2024 * |
-1.39
x | P/E ratio 2025 * |
-0.73
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | +3.34% | ||
1 week | -1.90% | ||
Current month | -2.88% | ||
1 month | -22.57% | ||
3 months | -60.48% | ||
6 months | -44.37% | ||
Current year | -37.21% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 70 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | 48 | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.05% | 1,487 M€ | +8.50% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 0.573 | +3.34% | 860,999 |
24-06-04 | 0.5545 | -4.48% | 1,018,819 |
24-06-03 | 0.5805 | -1.61% | 829,306 |
24-05-31 | 0.59 | +1.90% | 865,704 |
24-05-30 | 0.579 | -0.87% | 531,458 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.21% | 125M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- GOSS Stock